Class Action News
February 7, 2013
American Lawyer | Subscription Required | February 7, 2013
Ted Frank, the conservative legal activist and bane of allegedly unfair class action settlements, has picked yet another target. This time, it's a $15 million deal that Bayer Corp. reached in May with customers who accused the company selling overpriced and non-FDA approved aspirin.
Point of Law | February 7, 2013
Fewer than 20,000 class members have bothered to go through the arduous claim procedures in the Bayer Corp. class action, which caps recovery for most of those class members at $4 unless they saved several-year-old receipts for aspirin products. But the attorneys—led by Hagens Berman—are asking for $5.1 million for themselves.
February 6, 2013
Hindu Business Line | February 6, 2013
Companies Bill 2011, which was recently passed by the Lok Sabha, prescribes several new guidelines for corporate governance. The one that permits filing class action suits against companies has, in particular, raised curiosity amongst businesses and the public.
February 5, 2013
Forbes | February 5, 2013
The U.S. Supreme Court will soon hear arguments in a case that tests a philosophical question at the heart of modern tort law: If the cost of pursuing a lawsuit exceeds its value to an individual plaintiff, is that a bad thing?
Reuters | February 5, 2013
A groundbreaking proposal in Britain making it easier to bring antitrust class actions has business groups worldwide fearful that London will become a center for litigation abuses.
Law Society Gazette | February 5, 2013
A US industry body has added its voice to concerns about government plans to simplify collective actions under competition law.
February 4, 2013
Financial Times | Subscription Required | February 4, 2013
The White House is set to order stronger cybersecurity measures by the end of this month as a rash of unprecedented cyber attacks against financial institutions and energy companies are prompting some big companies to rethink the need for government intervention.
February 1, 2013
Wall Street Journal | Subscription Required | February 1, 2013
The maker of Zoloft is being sued in an unusual case alleging the popular antidepressant has no more benefit than a dummy pill and that patients who took it should be reimbursed for their costs.
American Lawyer | Subscription Required | February 1, 2013
On Wednesday a federal judge in Newark granted class certification in the eight-year-old case, which accuses Merck and certain executives of overstating the commercial promise of Vioxx despite its health risks.
Tags: Class Action
February 1, 2013
There were a number of significant class action developments in Canada in 2012, including the “landmark” $117 million E&Y settlement in the Sino-Forest case. The developments during the past year “suggest that 2013 may be a tipping point for the maturing class action jurisprudence in Canada.”
- News by Issue
- Arbitration & ADR
- Class Action
- Environmental Litigation
- Financial Services
- Foreign Corrupt Practices Act
- Government Contracts & Whistleblower Legislation
- Lawsuit Abuse Impact
- Legal Ethics
- Medical Liability
- Securities Litigation
- State Attorneys General
- Third-Party Litigation Financing
- Trial Lawyers' Influence
- News by State
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Rhode Island
- South Carolina
- South Dakota
- West Virginia
- ILR in the News
From The Blog
Today, the Colorado Court of Appeals ruled unanimously that lawsuit lenders cannot duck the state’s consumer lending...
The Oklahoma House of Representatives passed a bill (SB 1016) Wednesday to curb lawsuit lending abuses that will now...